[The Treatment of Olaparib for BRCA Positive-Metastatic Breast Cancer Patient]

MLA

Daigo, Yamamoto, et al. “[The Treatment of Olaparib for BRCA Positive-Metastatic Breast Cancer Patient].” Gan to Kagaku Ryoho. Cancerchemotherapy, vol. 48, no. 3, Apr. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........e81150e40357f18670be5031e6b2b342&authtype=sso&custid=ns315887.

APA

Daigo, Y., Chizuko, Y., Homa, O., Yu, T., & Katsuhiro, K. (2021). [The Treatment of Olaparib for BRCA Positive-Metastatic Breast Cancer Patient]. Gan to Kagaku Ryoho. Cancerchemotherapy, 48(3).

Chicago

Daigo, Yamamoto, Yamamoto Chizuko, Okugawa Homa, Tsubota Yu, and Kawakami Katsuhiro. 2021. “[The Treatment of Olaparib for BRCA Positive-Metastatic Breast Cancer Patient].” Gan to Kagaku Ryoho. Cancerchemotherapy 48 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........e81150e40357f18670be5031e6b2b342&authtype=sso&custid=ns315887.